Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs

• Publisher : GBI Research
• Date: May   2015

• Pages : 126
• Pricing : $4995
• All the fields * are required